Cancer
The Genomic Informatics group undertake NGS studies to identify mutations which may predispose to, or occur during, cancer development.
Read more
The Genomic Informatics group has many areas of active research, in partnership with local, national, and international collaborators.
The Genomic Informatics group undertake NGS studies to identify mutations which may predispose to, or occur during, cancer development.
We apply exome sequencing, along with immunological and microbiome testing to a rich local cohort of paediatric IBD patients in order to better understand the aetiology of IBD.
We develop and apply approaches for the investigation of LD patterns, and have applied these to many populations, human and otherwise.
We work to identify mutations underlying rare disease.
The Genomic Informatics group is involved in taking NGS into the clinic locally.
Meet the Genomic Informatics team.
See details of upcoming BINGS seminars and conferences.